Finance

Beta
Lists
IP:BKK
Inter Pharma PCL
THB 4.32
+0.93%
(+0.040) 1D
Jun 2, 4:40:00 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for IP...
Open
THB 4.30
High
THB 4.32
Low
THB 4.20
Mkt. cap
2.62B
Avg. vol.
298.32K
Volume
0.00
Dividend
1.69%
Quarterly dividend
THB 0.02
Ex-dividend date
May 6, 2026
P/E ratio
19.66
52-wk high
THB 4.70
52-wk low
THB 2.98
EPS
THB 0.22
Shares outstanding
605.34M
No. of employees
162
Open
THB 4.30
High
THB 4.32
Low
THB 4.20
Mkt. cap
2.62B
Avg. vol.
298.32K
Volume
0.00
Dividend
1.69%
Quarterly dividend
THB 0.02
Ex-dividend date
May 6, 2026
P/E ratio
19.66
52-wk high
THB 4.70
52-wk low
THB 2.98
EPS
THB 0.22
Shares outstanding
605.34M
No. of employees
162
News stories
From sources across the web
About Inter Pharma PCL
CEOTrinnawat Thanitnithiphan
Employees162
FoundedApr 20, 2006
Headquarters-
SectorPersonal care products
Websiteinterpharma.co.th
Previous reportsAll values in THB
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in THB
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
540.78M
563.47M
576.15M
562.08M
Cost of goods sold
322.72M
321.39M
337.26M
312.48M
Cost of revenue
322.72M
321.39M
337.26M
312.48M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
173.85M
176.97M
194.96M
194.52M
Operating expense
173.85M
176.97M
194.96M
194.52M
Total operating expenses
496.57M
498.36M
532.21M
507.00M
Operating income
44.21M
65.11M
43.93M
55.08M
Other non operating income
-
-
-
-
EBT including unusual items
38.99M
58.89M
39.51M
51.14M
EBT excluding unusual items
38.99M
58.89M
39.51M
51.14M
Income tax expense
7.38M
10.85M
10.37M
11.86M
Effective tax rate
18.92%
18.43%
26.24%
23.19%
Other operating expenses
-
-
-
-
Net income
28.22M
43.60M
25.44M
35.79M
Net profit margin
5.22%
7.74%
4.42%
6.37%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-5.25M
-5.02M
-4.42M
-3.94M
Net interest expenses
-5.25M
-5.02M
-4.42M
-3.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
64.12M
88.23M
62.13M
76.70M
Gain or loss from assets sale
357.00K
319.00K
782.62K
9.18M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer